NCT05117632 - ALTO-100 in MDD and/or PTSD | Biotech Hunter

Enrollment

245

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

December 9, 2022

Conditions

Major Depressive DisorderPost Traumatic Stress Disorder

Interventions

DRUG

ALTO-100 PO tablet

one tablet twice daily

Trial Locations (23)

21229

Site 151, Baltimore

33172

Site 112, Doral

33431

Site 150, Boca Raton

39216

Site 108, Jackson

44130

Site 146, Middleburg Heights

46060

Site 137, Noblesville

60123

Site 155, Elgin

68526

Site 142, Lincoln

72211

Site 139, Little Rock

76104

Site 147, Fort Worth

76244

Site 148, Fort Worth

77054

Site 120, Houston

77090

Site 113, Houston

84020

Site 121, Draper

85284

Site 136, Tempe

89102

Site 144, Las Vegas

92626

Site 141, Costa Mesa

93703

Site 118, Fresno

94553

Site 116, Martinez

95655

Site 116, Mather

98104

Site 105, Seattle

NTC Seattle (105a), Tacoma

02478

Site 109, Belmont